Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases

NCT01802645 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Cetuximab
DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: 5-FU
DRUG: Folinic Acid

Sponsor

Technische Universität Dresden